comscore Microsoft announces AI tool to diagnose cervical cancer faster | BGR India
News

National Cancer Awareness Day: Microsoft and SRL Diagnostics announce AI tool to diagnose cervical cancer faster

Check out how Microsoft and SRL Diagnostics built an AI tool to detect cervical cancer faster

  • Updated: December 10, 2019 5:08 PM IST
Microsoft AI cancer research

Photo: Microsoft


Microsoft in collaboration with SRL Diagnostics has created a new AI tool to diagnose cervical cancer faster. On the National Cancer Awareness Day, Microsoft has announced that the AI-powered cervical cancer screening API is currently in internal preview at SRL Diagnostics. According to estimates by the World Health Organization (WHO), cervical cancer is the fourth most frequent cancer among women worldwide. India accounts for 16 percent of the global burden of the disease. Also Read - Humans make safer user profiles than Artificial Intelligence: Study

The cervical cancer is also frequent in the rural regions of the country where literacy and awareness are low. In order to reduce its incidence, the two key factors are effective screening and early detection. SRL Diagnostics, the largest diagnostics laboratory company in India, has reportedly been witnessing an increase in the demand for cervical cancer screening. The two companies began collaboration to create an AI Network for Pathology in September 2018. It was designed to ease the burden of cytopathologists and histopathologists. Also Read - Facebook to use Artificial Intelligence to map world population

A digitally scanned version of a Whole Slide Imaging (WSI) slide (Photo: Microsoft)

“The proportion of cytopathologists in India is very low with respect to the number of patients,” said Dr. Arnab Roy, Technical Lead – New Initiatives & Knowledge Management, SRL Diagnostics. “We receive more than 100,000 Pap smear samples every year and there are only a few trained cytopathologists who are supposed to examine such slides,” he added. Roy added that 98 percent of these samples are normal and only remaining 2 percent require further intervention. The AI tool is designed to help cytopathologists find those remaining 2 percent of abnormal samples faster. Also Read - National Artificial Intelligence Portal to help boost sector: Goyal

The AI-powered cervical cancer screening API, according to Microsoft, does the first-level check and offloads normal slides. This means that cytopathologists now have more time to spend analyzing the slides that show signs of abnormality. “Our partnership with Microsoft to co-create solutions having the potential to generate both social and business value, is another first-of-its-kind effort in the Indian diagnostics industry,” Arindam Haldar, CEO, SRL Diagnostics, said.

In order to develop Cervical Cancer Image Detection API, the cytopathologists studied digitally scanned versions of Whole Slide Imaging (WSI) slides manually. They marked their observations, which were used as training data for the AI model. SRL Diagnostics initially appointed one cytopathologist to annotate the images slides. However, each WSI comprises of as many as 1,800 tile images, making it difficult for a single individual to interpret a large quantity of image tiles from each slide in ways that can be consumed by the AI algorithm.

“We wanted to create an AI algorithm that could identify areas that everybody was looking at and create a consensus on the areas assessed,” Manish Gupta, Principal Applied Researcher, Microsoft Azure Global Engineering, said in a released statement. The project then expanded to include five cytopathologists across multiple labs and different locations. These cytopathologists annotated thousands of tile images of cervical smear with each comprising about 300-400 cells.

“The collaboration has already started showing results with the first API for screening cervical cancer ready for internal preview at SRL Diagnostics,” Microsoft said. “The AI model can now differentiate between normal and abnormal smear slides with accuracy and is currently under validation in labs. It can also classify smear slides based on the seven-subtypes of cervical cytopathological scale.”

For the latest tech news across the world, latest PC and Mobile games, tips & tricks, top-notch gadget reviews of most exciting releases follow BGR India’s Facebook, Twitter, subscribe our YouTube Channel.
  • Published Date: November 7, 2019 4:50 PM IST
  • Updated Date: December 10, 2019 5:08 PM IST



new arrivals in india

Realme Narzo 20A
Realme Narzo 20A

8,499

Realme Narzo 20
Realme Narzo 20

10,499

Realme Narzo 20 Pro
Realme Narzo 20 Pro

14,999

Oppo F17
Oppo F17

17,990

Samsung Galaxy M51
Samsung Galaxy M51

24,999

Poco M2
Poco M2

10,999

Oppo F17 Pro
Oppo F17 Pro

22,990

Realme 7 Pro
Realme 7 Pro

19,999

Realme 7
Realme 7

14,999

Xiaomi Redmi 9A
Xiaomi Redmi 9A

6,799

Vivo Y20
Vivo Y20

12,990

Xiaomi Redmi 9
Xiaomi Redmi 9

8,999

Nokia 5.3
Nokia 5.3

13,999

Motorola Moto G9
Motorola Moto G9

11,499

Realme C15
Realme C15

9,999

Realme C12
Realme C12

8,999

Samsung Galaxy Note 20
Samsung Galaxy Note 20

77,999

Xiaomi Redmi 9 Prime
Xiaomi Redmi 9 Prime

9,999

Oppo Reno4 Pro
Oppo Reno4 Pro

34,990

Samsung Galaxy M01 Core
Samsung Galaxy M01 Core

5,499

Realme 6i
Realme 6i

12,999

Asus Rog Phone 3
Asus Rog Phone 3

49,999

OnePlus Nord
OnePlus Nord

24,999

Infinix Smart 4 Plus
Infinix Smart 4 Plus

7,999

Xiaomi Redmi Note 9
Xiaomi Redmi Note 9

11,999

Samsung Galaxy M01s
Samsung Galaxy M01s

9,999

Vivo X50 Pro 5G
Vivo X50 Pro 5G

49,990

Vivo X50 5G
Vivo X50 5G

34,990

Realme C11
Realme C11

7,499

Poco M2 Pro
Poco M2 Pro

13,999

Realme X3
Realme X3

24,999

Realme X3 SuperZoom
Realme X3 SuperZoom

27,999

Tecno Spark Power 2
Tecno Spark Power 2

9,999

Oppo A12
Oppo A12

9,990

Oppo A52
Oppo A52

16,990

Samsung Galaxy A21s
Samsung Galaxy A21s

15,999

Oppo Find X2
Oppo Find X2

64,990

Motorola One Fusion Plus
Motorola One Fusion Plus

17,499

Samsung Galaxy A31
Samsung Galaxy A31

20,999

Samsung Galaxy M01
Samsung Galaxy M01

8,999

Samsung Galaxy M11
Samsung Galaxy M11

10,999

Infinix Hot 9 Pro
Infinix Hot 9 Pro

9,999

LG Velvet
LG Velvet

Price Not Available

Xiaomi Mi Note 10 Lite
Xiaomi Mi Note 10 Lite

Price Not Available

Apple iPhone SE 2020
Apple iPhone SE 2020

42,500

Honor 30 Pro
Honor 30 Pro

Price Not Available

Honor 30
Honor 30

Price Not Available

OnePlus 8
OnePlus 8

44,999

OnePlus 8 Pro
OnePlus 8 Pro

54,999

Xiaomi Redmi Note 9 Pro
Xiaomi Redmi Note 9 Pro

13,999

Motorola Moto E4
Motorola Moto E4

8,999

Samsung Galaxy On Max
Samsung Galaxy On Max

9,775

nubia N2
nubia N2

15,999

Karbonn K9 Kavach 4G
Karbonn K9 Kavach 4G

5,290

Motorola Moto C Plus
Motorola Moto C Plus

6,999

Best Sellers